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A JNK-Dependent Pathway Is Required
for TNF-Induced Apoptosis
TNF-mediated apoptosis (De Smaele et al., 2001; Tang
et al., 2001). Despite the fact that sustained activation
of JNK promotes cell death, the molecular basis of how
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The intrinsic apoptotic pathway is the result of activa-Houston, Texas 70030
tion of mitochondria-mediated cell death events, includ-
ing changes in mitochondrial membrane permeability
and subsequent release of proapoptotic factors in-Summary
volved in various aspects of apoptosis (Wang, 2001).
The released factors include cytochrome c (cyto c; LiuTumor necrosis factor (TNF) receptor signaling can
et al., 1996a), apoptosis inducing factor (AIF) (Susin etsimultaneously activate caspase 8, the transcription
al., 1999), second mitochondria-derived activator of cas-factor, NF-B and the kinase, JNK. While activation of
pase (Smac or DIABLO) (Du et al., 2000; Verhagen etcaspase 8 is required for TNF-induced apoptosis,
al., 2000), Omi/HtrA2 (Suzuki et al., 2001), and endonu-and induction of NF-B inhibits cell death, the precise
clease G (Li et al., 2001). Cytosolic cyto c and Apaf-1function of JNK activation in TNF signaling is not
form an essential part of apoptosis complex and leadclearly understood. Here, we report that TNF-medi-
to the activation of caspase 9, which then processes andated caspase 8 cleavage and apoptosis require a se-
activates other caspases to orchestrate the biochemicalquential pathway involving JNK, Bid, and Smac/DIA-
execution of cells (Li et al., 1997).BLO. Activation of JNK induces caspase 8-independent
Although the apoptotic pathways through death re-cleavage of Bid at a distinct site to generate the Bid
ceptors and mitochondria are capable of operating inde-cleavage product jBid. Translocation of jBid to mito-
pendently, accumulating evidence suggests that achondria leads to preferential release of Smac/DIABLO,
crosstalk exists between the two pathways. One linkbut not cytochrome c. The released Smac/DIABLO then
between death receptor signaling and mitochondrialdisrupts the TRAF2-cIAP1 complex. We propose that
pathway comes from the finding that the BH3-domainthe JNK pathway described here is required to relieve
only protein Bid is cleaved and activated by active cas-the inhibition imposed by TRAF2-cIAP1 on caspase
pase 8. The truncated Bid (tBid) translocates to mito-8 activation and induction of apoptosis. Further, our
chondria and triggers cyto c release (Li et al., 1998; Luofindings define a mechanism for crosstalk between
et al., 1998). We have shown that caspase 8-Bid-Bax-intrinsic and extrinsic cell death pathways.
depedent intrinsic pathway is required for TRAIL- and
FasL-mediated apoptosis in human cancer cells (DengIntroduction
et al., 2002).
Studies on the function of mitochondria in TNF-Activation of death receptor TNFR1 (tumor necrosis fac-
induced apoptosis have been complicated by the facttor receptor 1) by TNF leads to the recruitment of
that TNF-induced apoptosis requires the inhibition ofTNFR1-associated death domain protein (TRADD),
NF-B. Most of previous studies achieved this bywhich serves as a platform to form various signaling
blocking RNA or protein synthesis using actinomycin Dcomplexes involved in different biological processes
(Act D) or cyclohexamide (CHX), which inevitably affect
(Baud and Karin, 2001). For instance, TRADD can recruit
many other biological processes. To better address the
FADD and lead to caspase 8 activation and apoptosis
function of mitochondria in TNF-mediated apoptosis
through the extrinsic pathway (Hsu et al., 1996b). How- and to elucidate the role of JNK in TNF signaling, we
ever, TNF is not cytotoxic to most cells, because used small interfering RNA (siRNA) to block TNF-
TRADD can recruit TRAF2 (TNF-receptor-associated mediated JNK activation in p65/ cells and in cells
factor 2) and RIP to form distinct complexes leading to expressing a mutant of iB (Reuther and Baldwin,
the activation of NF-B and JNK (Hsu et al., 1996a, 1999). We report that unlike TRAIL- and FasL-induced
1996b; Lee et al., 1997). It has been well established apoptosis where mitochondria act downstream of cas-
that activation of NF-B serves as a primary mechanism pase 8 (Deng et al., 2002), TNF-mediated caspase 8
to protect cells against apoptotic stimuli such as TNF activation requires activation of mitochondria pathway.
(Beg and Baltimore, 1996; Van Antwerp et al., 1996; We further show that a pathway involving TNF-medi-
Wang et al., 1996). Therefore, TNF-induced apoptosis ated activation of JNK, JNK-induced caspase 8-inde-
requires NF-B inhibition. pendent cleavage of Bid, and Bid-induced preferential
The involvement of JNK in TNF-mediated apoptosis release of Smac from mitochondria, is required for
is highly controversial (De Smaele et al., 2001; Liu et al., TNF-mediated caspase 8 activation and apoptosis.
1996b; Natoli et al., 1997; Tang et al., 2001). Recently,
induction of NF-B has been shown to inhibit TNF- Results
mediated JNK activation and blocking NF-B results in
sustained activation of JNK, which may directly promote Mitochondria Pathway Is Critical for
TNF-Induced Caspase 8 Activation and Apoptosis
To test the function of mitochondria in TNF-mediated*Correspondence: xiangwei@bcm.tmc.edu
1These authors contributed equally to this work. apoptosis, a mutant of iB (m-iB) was used to inhibit
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Figure 1. Mitochondria Pathway Is Critical
for TNF-Mediated Caspase 8 Activation
and Apoptosis
(A) HeLa cells were transfected with either
m-iB or m-iB and Bcl-xl (HA-tagged) for 48
hr. A green fluorescent protein (GFP) express-
ing plasmid (pEGFP-C1, Clontech) was co-
transfected to monitor the transfection effi-
ciency and to mark the transfected cells. The
cells were treated with TNF (50 ng/ml) for 8
hr and pictures were taken.
(B) HeLa cell extracts were prepared from
cells described in (A) and analyzed with anti-
bodies specifically recognizing cleaved hu-
man caspase 8 (Casp 8) and cleaved PARP
(C-PARP), respectively. Transfected Bcl-xl
was detected by anti-HA antibody. Endoge-
nous iB and transfected m-iB were de-
tected by an anti-iB antibody. Expression of
tubulin was used as loading controls.
(C) p65/ MEFs were transfected with either control vector or Bcl-xl and stable cell lines were established. Expression of Bcl-xl was analyzed
by Western blots using an anti Bcl-xl antibody and tubulin was used as loading control.
(D) p65/ and p65//Bcl-xl cells were treated by TNF (10 ng/ml) for indicted time points. The apoptotic cells were counted by trypan blue
exclusion and percentages of cell death were plotted. The data are derived from two independent experiments.
(E) Western blot analysis of procaspase 8 expression in TNF-treated cells using an anticaspase 8 antibody. Three independent cell lines
were tested and similar results were obtained.
NF-B activation in HeLa cells. Transfection of m-iB structed a plasmid expressing siRNA for human MKK7
(MKK7siRNA) in the pSUPER siRNA vector (Brummel-alone had no effect on cell viability but resulted in cell
death after TNF treatment as cells became rounded, kamp et al., 2002). MKK7, also known as JNKK2, has
been shown to be the JNK upstream kinase requiredshrank, and detached (Figure 1A). Coexpression of Bcl-
xl significantly blocked the TNF toxicity (Figure 1A). for TNF-induced JNK activation (Tournier et al., 2001).
The MKK7siRNA was transfected into HeLa cells ex-Western blotting showed that TNF-induced caspase 8
cleavage in cells transfected with m-iB, but the cleav- pressing m-iB (HeLa-m-iB) and TNF-mediated JNK
activation was analyzed. While expression of MKK7siRNAage was inhibited by the expression of Bcl-xl (Figure
1B). Cleavage of Poly (ADP-ribose) polymerase (PARP) has no effect on total JNK (JNK1 and JNK2) expression,
it greatly reduced MKK7 protein expression and pre-correlated with caspase 8 cleavage and apoptosis (Fig-
ure 1B). Analysis of caspase 8 and caspase 3 enzyme vented JNK activation in response to TNF as TNF-
induced phosphorylation of JNK was inhibited (Figureactivities in these cells correlated with the Western blot-
ting results (data not shown). The ability of Bcl-xl to 2A). To better mark the MKK7siRNA expressing cells,
we cloned a green fluorescent protein (GFP) expressioninhibit TNF-mediated caspase 8 activation and apopto-
sis was also tested in mouse embryonic fibroblast (MEF) cassette into the MKK7siRNA vector. This MKK7siRNA-
GFP plasmid was transfected into HeLa-m-iB cells.cells lacking the endogenous p65 or RelA subunit of
NF-B (p65/). Consisting with the results in HeLa Expression of GFP alone had no effect on TNF-induced
cell death as cells turned apoptotic, while coexpressingcells, expression of Bcl-xl significantly inhibited TNF-
induced apoptosis in p65/ cells (Figures 1C and 1D). MKK7siRNA inhibited cell death induced by TNF (Fig-
ure 2B). Expression of MKK7siRNA also blockedFurthermore, Bcl-xl also blocked TNF-induced cas-
pase 8 cleavage even after prolonged treatment (Figure TNF-induced cleavage of caspase 8 (Figure 2C). To
further strengthen this observation, p65/ MEF stable1E). Similar experiments were also performed in human
colon cancer HCT116 cells and identical results were cell lines expressing mouse MKK7siRNA were estab-
lished. Stably expressing MKK7siRNA effectively blockedobtained (data not shown). These data suggest that the
intrinsic pathway is required not only for TNF-mediated the expression of endogenous MKK7 and TNF-induced
JNK activation (Figure 2D). Furthermore, MKK7siRNAapoptosis, but also for TNF-induced caspase 8 activa-
tion. The later is distinct to TRAIL and FasL-induced significantly inhibited TNF-mediated apoptosis in
p65/ cells (Figures 2E and 2F). More importantly,caspase 8 activation, which is independent of mitochon-
dria (Deng et al., 2002). MKK7siRNA expression blocked TNF-induced cas-
pase 8 cleavage and activation (Figure 2G). These data
strongly support that JNK activation is required forTNF-Mediated Caspase 8 Activation and
Apoptosis Require JNK Activation TNF-induced caspase-8 activation and apoptosis.
Since mitochondria events are required for TNF-medi-
ated caspase 8 activation and apoptosis, it raised two Induction of Preferential Smac Release
by TNF-Mediated JNK Activationimportant questions: what is the molecular basis of
TNF-induced activation of mitochondria pathway and To explore the role of TNF-mediated JNK activation in
regulating mitochondria events, we proceeded to inves-how do mitochondria signals regulate TNF-mediated
caspase 8 activation? To address the first question, we tigate whether JNK activation by TNF affected the sub-
cellular localization of cyto c and Smac. To exclude thefocused on TNF-induced JNK activation. We con-
JNK, Bid, and Smac/DIABLO in TNF Signaling
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Figure 2. Inhibition of JNK Blocks TNF-Mediated Caspase 8 Activation and Apoptosis
(A) MKK7siRNA blocks TNF-mediated JNK activation. HeLa cells stably expressing m-iB were transfected with either vector pSUPER or
MKK7siRNA. Cells were treated with TNF (50 ng/ml) for time indicated after 48 hr transfection and expression of MKK7; total JNK (T-JNK1/2)
and phosphorylated JNK (P-JNK1/2) were analyzed by Western blots.
(B) HeLa-m-iB cells were transfected with either GFP or MKK7siRNA-GFP for 48 hr and treated by TNF (50 ng/ml). Pictures were taken 12
hr after TNF treatment.
(C) Western analysis of MKK7 and cleaved caspase 8 in HeLa-m-iB cells transfected with GFP and MKK7siRNA-GFP.
(D) p65/ and p65/ stably expressing MKK7siRNA were treated with TNF (10 ng/ml) for time indicated. Whole-cell extracts were analyzed
by Western blots for MKK7, P-JNK1/2, and T-JNK1/2.
(E) The control p65/ and p65/ stably expressing MKK7siRNA were treated with TNF. The pictures were taken 8 hr after TNF treatment.
(F) Apoptotic cells were counted at multiple fields and percentages of survival cells were plotted. The data are the average of two indepen-
dent experiments.
(G) TNF treated cells were analyzed for procaspase 8 expression by Western blots. Tubulin was used as loading control. Three independent
cell lines were tested and similar results were obtained.
possibility that activation of mitochondria pathway is induced redistribution of Smac-GFP to diffused cyto-
solic pattern (Figure 3C). While less than 20% of Smac-the result of TNF-induced caspase 8 activation, we
established stable cell lines expressing a dominant-neg- GFP expressing cells showed cytosolic GFP before
TNF treatment, more than 75% of the Smac-GFP be-ative mutant of FADD (FADD-DN) using p65/ MEFs
(Chinnaiyan et al., 1995). Consistent with previous re- came cytosolic after TNF stimulation (Figure 3D). More
importantly, expression of MKK7siRNA inhibited Smacports, expression of FADD-DN blocked TNF-mediated
caspase 8 activation and apoptosis without affecting translocation by more than 4-fold (Figures 3C and 3D).
These results indicate that TNF-activated JNK, func-TNF-induced JNK activation (Liu et al., 1996b and data
not shown). Immunostaining of p65/ FADD-DN cells tioning upstream of mitochondria, is required for TNF-
induced preferential release of Smac.showed that both cyto c and Smac displayed punctu-
ated perinuclear pattern before TNF treatment, indica- It has been shown that inhibition of NF-B resulted
in sustained activation of JNK induced by TNF (Detive of mitochondria localization. The mitochondria
staining pattern was confirmed using MitoTracker (data Smaele et al., 2001; Tang et al., 2001). To test whether
sustained JNK activation is sufficient to induce preferen-not shown). The staining pattern of the Smac protein
after TNF treatment became diffused, indicative of cy- tial release of Smac from mitochondria, a constitutive
active JNK expression vector JNK-MKK7-wt and its ki-tosol localization, while cyto c was not affected (Figure
3A). These results suggest that TNF signaling leads nase inactive mutant JNK-MKK7-kd were transfected
into HeLa-m-iB-FADD-DN cells along with eitherto preferential release of Smac from mitochondria in a
caspase 8-independent manner. To test whether Smac Smac-GFP or a Cyto C-GFP fusion protein (Figure 3E).
Expression of JNK-MKK7-wt, but not the JNK-MKK7-is also preferentially released in TNF signaling pathway
in other cell types, we established HCT116 cell lines kd induces sustained JNK activation in HeLa cells as
reported (Rennefahrt et al., 2002 and data not shown).stably expressing both m-iB and FADD-DN (data not
shown). The subcellular fraction results showed that More importantly, JNK-MKK7-wt, but not JNK-MKK7-
kd specifically resulted in mitochondrial release ofafter TNF stimulation, Smac was released from mito-
chondria to cytosol, but majority of cyto c remained in Smac-GFP without affecting Cyto C-GFP distribution
(Figure 3F), suggesting that sustained JNK activation ismitochondria (Figure 3B).
To investigate if JNK activation acts upstream of Smac capable of inducing preferential release of Smac from
mitochondria.redistribution, a Smac-GFP fusion protein was cotrans-
fected with either vector control or MKK7siRNA into HeLa
cell lines stably expressing both m-iB and FADD-DN (Fig- Bid Acts Downstream of JNK in TNF Signaling
to Mitochondriaure 3C). Similar to endogenous Smac, the Smac-GFP was
expressed in mitochondria in untreated HeLa-m-iB- Since Bid has been shown to act as a link between
mitochondria and death receptor pathways induced byFADD-DN cells as Smac-GFP showed punctuated perinu-
clear mitochondrial pattern (Figure 3C). TNF treatment FasL and TRAIL (Deng et al., 2002), it is possible that
Cell
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Figure 3. TNF-Induced Mitochondria Smac Release Requires JNK Activation
(A) p65/FADD-DN cells were treated for 4 hr with or without TNF (10 ng/ml). The cells were stained for either cytochrome c or Smac
proteins. DNA was visualized by staining with Hoechst 3342.
(B) Mitochondria (Mito) and cytosolic (Cyto) extracts of TNF-treated (50 ng/ml) and untreated HCT116-m-iB-FADD-DN cells were blotted
for Smac and cytochrome c expression. Mitochondria CoxIV and cytosolic actin were used as subcellular fraction controls.
(C) HeLa-m-iB-FADD-DN cells were transiently transfected with plasmids pSUPER and Smac-GFP, or Smac-GFP and MKK7siRNA. Distribution
of Smac-GFP was viewed under a fluorescent microscope before and after TNF treatment for 12 hr (50 ng/ml).
(D) GFP positive cells were counted at multiple fields and percentages of cytosolic GFP cells were plotted. The data are derived from three
independent experiments.
(E) JNK-MKK7-wt and JNK-MKK7-kd (Myc-tagged) were transiently transfected into HeLa-m-iB-FADD-DN cells along with either Smac-GFP
or a Cyto C-GFP. Expression of JNK-MKK7 proteins was analyzed using anti-Myc antibody.
(F) GFP positive cells were counted at multiple fields and percentages of cytosolic GFP cells were plotted. The data are derived from three
independent experiments.
Bid may function downstream of JNK to transduce TNF expression had no effect on TNF-induced decrease
in Bid protein levels, while expression of MKK7siRNAsignal to mitochondria. To test this hypothesis, we
first proceeded to examine Bid expression in TNF- prevented Bid reduction (Figure 4A), suggesting that
TNF is capable of inducing caspase 8-independentmediated apoptosis. In p65/ cells, TNF treatment led
to a reduction in full-length Bid protein levels as Bid can but JNK-dependent Bid cleavage. Similar results were
obtained in HeLa cells (Figure 4B). To explore whetherbe cleaved by activated caspase 8 as reported (Li et al.,
1998; Luo et al., 1998) (Figure 4A). However, inhibition JNK-induced Bid cleavage leads to translocation of
cleaved Bid to mitochondria, we generated a Bid andof TNF-mediated caspase 8 cleavage by FADD-DN
GFP fusion protein at the C-terminal of Bid. Transfection
of Bid-GFP into HeLa-m-iB-FADD-DN cells resulted in
most cells in diffused cytosolic GFP expression pattern,
consistent with the fact that full-length Bid resides in
cytosol (Figure 4C). After TNF treatment, most of GFP
displayed punctuated mitochondria pattern (Figure 4C)
and colocalized with mitochondria marker MitoTracker
(data not shown). Cotransfecting with MKK7siRNA sig-
nificantly inhibited GFP fluorescence distribution to mi-
tochondria (Figure 4C). These data suggest that TNF
induces a caspase 8-independent and JNK-dependent
Bid cleavage and subsequent translocation of cleaved
Bid to mitochondria.
Figure 4. Caspase 8-Independent and JNK-Dependent Bid Cleav-
age in TNF Signaling Induction of Preferential Smac Release
(A) p65/ and p65/ stable cell lines expressing MKK7siRNA or by JNK-Activated Bid
FADD-DN were treated with TNF (10 ng/ml) for time indicated. Caspase 8 cleaved product tBid has been shown to
Expression of full-length Bid was analyzed using a mouse specific induce apoptosis via mitochondria (Li et al., 1998; Luo
anti-Bid antibody.
et al., 1998). However, our results illustrate that JNK-(B) HeLa-m-iB-FADD-DN cells were transiently transfected with
induced Bid cleavage is incapable of killing cells, sug-either pSUPER vector or MKK7siRNA. After 48 hr, the transfected
cells were treated with TNF (50 ng/ml) for 12 hr. HeLa cells were gesting that the Bid cleavage product generated by JNK
treated with TRAIL (100 ng/ml) for 6 hr. Expression of Bid and MKK7 activation is different. As a first step to test this possibil-
was examined by Western blots. ity, an in vitro Bid cleavage assay was established. Cyto-
(C) HeLa-m-iB-FADD-DN cells were transiently transfected with sol extracts were prepared from TNF-treated HeLa-m-
either Bid-GFP or Bid-GFP and MKK7siRNA. The transfected cells
iB-FADD-DN cells and cells expressing MKK7siRNA.were treated with TNF (50 ng/ml) for 12 hr. Mitochondrial GFP
The extracts were incubated with an in vitro translatedfluorescence was counted and plotted and pictures were taken. The
data represents three independent experiments. Bid protein. While full-length Bid migrates around 24
JNK, Bid, and Smac/DIABLO in TNF Signaling
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Figure 5. Identification and Characterization of JNK-Mediated Bid Cleavage
(A) In vitro JNK-mediated Bid cleavage. In vitro translated Bid protein labeled with 35S-methionine was incubated with cytosol extracts prepared
from either TNF-treated or nontreated HeLa-m-iB-FADD-DN and HeLa-m-iB-FADD-DN cell expressing MKK7siRNA. The reaction mix was
separated on a 12% SDS-PAGE and subject to autoradiography. In vitro translated tBid protein labeled with 35S-methionine was used as
size comparison.
(B) In vivo JNK-mediated Bid cleavage. HeLa-m-iB and HeLa-m-iB-FADD-DN cells were transfected with Bid-GFP and treated with TNF
(50 ng/ml) for 8 hr. Transfected Bid proteins were detected by an anti-GFP monoclonal antibody (Santa Cruz). HeLa cells transfected with
tBid-GFP were used as size comparison.
(C) Detection of endogenous jBid. HeLa-m-iB-FADD cells were transfected with either MKK7siRNA or pSUPER vector. After 48 hr, cells were
treated with or without TNF (50 ng/ml) for 6 hr. Expression of Bid and MKK7 were detected by Western blots. Tubulin was used as loading
control. The experiments were repeated multiple times and representative results were presented.
(D) Bid-GFP or GFP fused deletion mutants of Bid was transfected into HeLa cells. Subcellular localization of transfected proteins was observed
using GFP fluorescence and mitochondria localization was verified by colocalizing with MitoTracker-Red (Molecular Probes). Apoptosis were
plotted as described in Figure 1D. Data represents the average of two independent experiments.
(E) Size comparison of jBid with Bid deletion mutants. Extracts from HeLa cells transfected with either Bid12-GFP, or Bid25-GFP, or Bid30-
GFP, or Bid40-GFP, and extract from TNF treated HeLa-m-iB-FADD-DN cells transfected with Bid-GFP were separated on a 7% SDS-
PAGE. The transfected proteins were detected by an anti-GFP monoclonal antibody.
(F) In vitro cleavage of Bid mutants. Wild-type full-length Bid and alanine scanning mutants of Bid for amino acid 23–27 were transcripted
and translated and labeled with 35S-methionine (top image) and subject to in vitro Bid cleavage assay using extracts of TNFa-treated HeLa-
m-iB-FADD-DN cells as described in Figure 5A (bottom image). The nonspecific band generated by in vitro translation was indicated by an *.
(G) Bid25-GFP was transfected into HeLa cells and cells were stained for either cytochrome c or Smac proteins. DNA was visualized by
staining with Hoechst 3342.
(H) Bid-GFP, Bid25-GFP, and tBid-GFP were separately transfected into HeLa cells. Smac and Cyto C localization were examined by
immunostaining. Data from three independent experiments were plotted.
kDa on a SDS-PAGE as predicated, reaction with HeLa-m-iB-FADD-DN and HeLa-m-iB cells. The
cleavage of Bid-GFP was analyzed by Western blottingTNF-treated HeLa-m-iB-FADD-DN extract generated
a specific Bid cleavage product migrating approximately using antibody against GFP (Figure 5B). Expression of
Bid-GFP in HeLa-m-iB cells resulted in the generationat 21 kDa (jBid for JNK-mediated cleaved Bid) (Figure
5A). The in vitro translated tBid (caspase 8 cleaved) of tBid-GFP after TNF treatment, comparable to trans-
fected tBid-GFP in HeLa cells (Figure 5B). A larger jBid-displayed molecular weight around 15 kDa (Figure 5A).
These results suggest that TNF-JNK activation results GFP cleavage product was detected when Bid-GFP ex-
pressing in HeLa-m-iB-FADD-DN cells were treatedin the generation of a unique Bid cleavage product jBid,
which is distinct to caspase 8 cleaved product tBid. by TNF (Figure 5B). To demonstrate the existence of
endogenous jBid in TNF signaling, HeLa-m-iB-FADD-More importantly, addition of extracts prepared from
MKK7siRNA expressing cells failed to induce Bid cleav- DN cells were transiently transfected with either
MKK7siRNA or vector control and cell extracts were ana-age (Figure 5A), suggesting that generation of jBid re-
quires the activation of JNK. To further confirm the in lyzed by Western blotting. Transfection of MKK7siRNA
significantly inhibited MKK7 expression (Figure 5C).vitro cleavage results, Bid-GFP was transfected into
Cell
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When cleavage of Bid was analyzed, a faster migrating or Bid/ MEFs (Figure 6A). As expected, no Bid protein
expression was detected in Bid/ cells (Figure 6A). Ex-band than the full-length Bid was detected in cells trans-
fected with vector control after TNF treatment with cor- pression of GFP-m-iB in wild-type MEFs, but not in
Bid/ MEFs, resulted in cell death after TNF treatmentresponding decrease in the levels of full-length Bid, but
not in MKK7siRNA-transfected cells (Figure 5C). The as GFP-m-iB expressing cells became apoptotic (Fig-
ure 6B), suggesting that Bid is required for TNF-endogenous jBid band migrated around 21 kDa and is
similar in size as the in vitro cleaved jBid (Figure 5A and mediated apoptosis. To further explore function of Bid
on TNF-mediated caspase 8 activation, we con-data not shown).
It has been shown that caspase 8 cleaves human Bid structed a plasmid expressing both Bid small interfering
RNA (BidsiRNA) and GFP to inhibit Bid expression inat amino acid position 60 (D60) to generated tBid. The
finding that jBid is larger than tBid suggests that jBid is HeLa-m-iB cells. Expression of BidsiRNA-GFP greatly
reduced the endogenous full-length Bid expressiongenerated by a cleavage closer to Bid’s N terminus.
Furthermore, since the generation of jBid is not sufficient while cells transfected with only GFP contained readily
detectable full-length Bid (Figure 6C). Furthermore, cas-to induce cell death, it suggests that the difference in
Bid cleavage site at Bid N-terminal region may lead to pase 8 was activated as cleaved caspase 8 appeared
and Bid was cleaved as the level of the full-length Bidthe generation of Bid cleavage products possessing
distinct proapoptotic potentials. To test this hypothesis, protein was greatly reduced in GFP transfected HeLa-
m-iB cells after TNF treatment (Figure 6C). Expressionwe generated a series N-terminal deletion mutants of
Bid. Deletion of the first 12 amino acids of Bid had little of BidsiRNA in HeLa-m-iB cells inhibited TNF-medi-
ated caspase 8 activation, as there was a significanteffect on its protein localization and cell death inducing
capability when transfected into HeLa cells (Figure 5D). reduction in the level of cleaved caspase 8 (Figure 6C).
The mitochondrial release of Smac was also blockedRemoval of 25 amino acid or more of Bid’s N-terminal
sequences resulted in Bid translocation from cytosol to (data not shown). Counting apoptosis of GFP expressing
cells showed that GFP alone had no effect on TNF-mitochondria. Of these mutants, only the mutant with
deletion of the first 25 amino acids (Bid25) showed induced apoptosis, while coexpression of BidsiRNA sig-
nificantly inhibited TNF-induced cell death (Figure 6D).potential to translocate to mitochondria, but did not
induce cell death (Figure 5D). More importantly, this These results indicate that Bid acts upstream of caspase
8 and is required for TNF-mediated caspase 8 activa-mutant was similar in size as the jBid protein (Figure
5E), suggesting that activation of JNK resulted in Bid tion and apoptosis.
To test the function of JNK-dependent cleavage defi-cleavage around amino acid position 25. To further nar-
row down the JNK-mediated Bid cleavage site, alanine cient mutant Bid (BidL25A) in TNF pathway, BidL25A
(GFP fusion protein) was transfected into HeLa-m-iB-scanning mutants around amino acid position 25 were
generated and subject to in vitro cleavage reactions. FADD-DN cells and no Bid cleavage was detected after
TNF treatment (Figure 6E), consistent with in vitro BidSerendipitously, mutation in amino acid position 25 re-
sulted in a completely loss of Bid cleavage, while muta- cleavage assay (Figure 5F). However, BidL25A still can
be cleaved by active caspase 8 (data not shown). Whiletions of other amino acids had no effect on JNK-medi-
ated Bid cleavage (Figure 5F). These results suggest transfection of wild-type Bid restored TNF-mediated
apoptosis in Bid/ MEFs, expression of BidL25A hadthat jBid is generated by a proteolytic cleavage at amino
acid position 25 and Bid25 is or very similar to jBid. To no effect on cell death (Figure 6F), suggesting that JNK-
mediated Bid cleavage at position 25 is critical for TNFinvestigate if Bid25 is capable of inducing preferential
Smac release, HeLa cells transfected with GFP-Bid25 signaling to apoptosis.
were immunostained with either an anti-Smac or an anti-
cyto c antibody (Figure 5G). The results showed that Activation of Smac Bypasses JNK and
expression of Bid25 lead to redistribution of Smac pro- Mitochondria Requirement in Promoting
tein staining patterns from mitochondria to cytosol (Fig- TNF-Mediated Caspase 8 Activation
ures 5G and 5H). Consistent with the fact Bid25 is To test whether Smac may function as the mitochondria
not cytotoxic, no cyto c release was observed in cells signal to regulate TNF-mediated caspase 8 activation,
expressing Bid25 (Figures 5G and 5H). In contrast, full- a recently developed expression system using ubiquitin
length Bid had little effect on the redistribution of either fusion to produce mature and active Smac in cytosol of
Smac or cyto c, while tBid induced mitochondrial release transfected cells was utilized to deliver active Smac into
of both of these factors (Figure 5H). These results HeLa cells (Hunter et al., 2003). Transfection of Ub-Smac
strongly support the notion that TNF activates JNK to (active Smac), but not the Ub-AVPI-Smac (inactive
lead to a caspase 8-independent cleavage of Bid at Smac) cooperated with TNF in inducing caspase 8
amino acid position 25 to generate a 21 kDa cleavage cleavage and apoptosis (Figures 7A and 7B). Since Ub-
product jBid. The jBid protein then translocates to mito- AVPI-Smac lacks IAP binding sequence, it further sug-
chondria to induce preferential release of Smac. gests that the activity of Smac in TNF pathway requires
its interaction with IAP family proteins. To support this
notion, a cell-permeable peptide derived from Smac
Bid Acts Upstream of Caspase 8 Activation protein sequence containing the domain required for IAP
in TNF Signaling binding (N-7) was added into HeLa-m-iB-MKK7siRNA
To test the function of Bid in TNF-signal transduction cells. A noncell permeable Smac peptide (N7-NP) was
to cell death, we first constructed a GFP and m-iB used as negative control. Treating HeLa-m-iB cells with
TNF resulted in caspase 8 activation and coexpressingfusion protein and transfected it into either the wild-type
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Figure 6. Requirement of Bid for TNF-Mediated Caspase 8 Activation and Apoptosis
(A) GFP-m-iB was transiently transfected into Bid/ and wild-type MEFs. The cells were treated with TNF (10 ng/ml) for 12 hr and expression
of Bid; GFP-m-iB was examined by Western blots.
(B) Morphology of GFP positive cells as described in (A).
(C) HeLa-m-iB cells were transfected with either GFP or BidsiRNA-GFP for 48 hr. The cells were treated with TNF (50 ng/ml) for 16 hr.
Expression of Bid and cleaved caspase 8 were examined by Western blots.
(D) Cells were counted at multiple fields and percentages of apoptotic cells were plotted.
(E) JNK-mediated cleavage of wild-type and L25A mutant Bid in cells. Bid-GFP or BidL25A-GFP was transfected into HeLa-m-iB-FADD-DN
cells and Western analysis was performed as in Figure 5B.
(F) Rescue of TNF-mediated apoptosis in Bid/ cells. Bid/ MEFs were transfected with either Bid-GFP or BidL25A-GFP along with m-iB.
The transfected cells were treated with TNFa and percentages of apoptosis were plotted.
of MKK7siRNA inhibited caspase 8 cleavage as ex- Smac and GFP (SmacsiRNA-GFP) was transfected into
HeLa-m-iB cells. Expression of SmacsiRNA-GFPpected (Figure 7C). Addition of N-7, but not N-7NP, co-
operated with TNF to induce caspase 8 activation and greatly reduced Smac protein levels (Figure 7D). More
importantly, SmacsiRNA-GFP significantly inhibitedapoptosis in HeLa-m-iB-MKK7siRNA cells (Figure 7C).
These results suggest that Smac is sufficient to rescue TNF-mediated caspase 8 cleavage and apoptosis by
4-fold (Figures 7D and 7E). Similar results were obtainedTNF-induced caspase 8 activation and apoptosis in
cells deficient in JNK activation and Smac acts down- in HCT116 cells stably expressing SmacsiRNA (data not
shown). These results indicate that Smac plays a pivotalstream of JNK and mitochondria in TNF signaling to
caspase 8 activation and cell death. role at downstream of JNK-Bid-mitochondria pathway
in regulation of TNF-mediated caspase 8 activation
and apoptosis in these cells.TNF-Mediated Caspase 8 Activation
and Apoptosis Require Endogenous Smac It has been shown that cIAP1 and cIAP2 are recruited
to the TNF signaling complex by TRAF2 and coexpres-To Investigate the involvement of endogenous Smac in
TNF signaling, a plasmid expressing both siRNA of sion of TRAF2 and cIAP1 significantly inhibited TNF-
Figure 7. Smac Is Involved in TNF-Medi-
ated Caspase 8 Activation and Apoptosis
(A) HeLa cells were transfected with GFP and
either Ub-Smac or Ub-AVPI-Smac (HA-
tagged), and cells were treated with TNF
(50 ng/ml) for 16 hr. Expression of Smac and
cleaved caspase 8 were detected using anti-
HA and anti-human cleaved caspase 8 anti-
bodies, respectively.
(B) Quantitation of apoptosis of GFP positive
cells in (A) was plotted.
(C) HeLa-m-iB (m-iB) and HeLa-m-iB-
MKK7siRNA (m-iB-MKK7siRNA) cells were
treated with Smac peptide N7 (50M), control
peptideN7-NP (50M), and TNF (50 ng/ml)
in various combinations as indicated and cell
extracts were analyzed for cleaved caspase
8 by Western blots.
(D) GFP and SmacsiRNA-GFP were transfected into HeLa-m-iB cells for 48 hr. Cells were treated with TNF (50 ng/ml) for 16 hr. Expression
of Smac and cleaved caspase 8 were analyzed by Western blotting.
(E) Percentage of apoptosis in GFP positive cells described in (D) was plotted. Three independent experiments were performed.
(F) N7 leads to TRAF2-cIAP1 dissociation. HeLa cells were treated for 1 hr with either TNF (50 ng/ml) or TNF and N7 (50M). Whole-cell
extracts were immunoprecipitated with an antibody against TRAF2 and blotted with anti-cIAP1 and anti-TRAF2 antibodies respectively. Ig:
immunoglobulin heavy chain.
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mediated caspase 8 activation, suggesting that cIAP1 Further, our model is consistent with the results that
coexpression of TRAF2 and cIAP1, but not individually,and TRAF2 function as a complex to regulate TNF-
strongly inhibits TNF-induced apoptosis in p65 nullmediated caspase 8 cleavage (Park et al., 2000; Wang
cells (Wang et al., 1998). To further support this hypothe-et al., 1998). We observed that IAP binding sequence is
sis, we have shown that active Smac, but not the mutantrequired and sufficient to cooperate with TNF in cell
lacking cIAP1 binding sequences, sensitizes TNF-death signaling (Figures 7A and 7B), thus, it is possible
induced caspase 8 activation, and a Smac peptide con-that Smac acts on the TRAF2-cIAP1 complex to promote
taining the cIAP1 binding domain is sufficient to disruptTNF-mediated caspase 8 activation. To support this
TRAF2-cIAP1 interaction and cooperate with TNF tohypothesis, we found that addition of N-7 peptide dis-
induce cell death.rupted the association of TRAF-2 and c-IAP1 after TNF
The TNF-JNK-jBid-Smac pathway defines anothertreatment (Figure 7F). Therefore, it is likely that release
mechanism for the crosstalk between intrinsic and ex-of Smac from mitochondria disrupts TRAF2-cIAP1 com-
trinsic cell death pathways. This pathway is distinct toplex and its inhibition on caspase 8 activation.
Fas- and TRAIL-induced apoptosis where Bid acts
downstream of caspase 8 and mitochondrial release ofDiscussion
Smac acts on XIAP to facilitate caspase 3 activation
(Deng et al., 2002). Interestingly, recent reports haveWe have shown that a sequential pathway involving
shown that Eiger, the Drosophila homolog of TNF su-JNK, Bid, mitochondria, and Smac is required for TNF-
perfamily, activates Drosophila homologs of JNK to in-mediated apoptosis. In wild-type cells, TNF treatment
duce apoptosis through Hid, Reaper, and Grim (Igaki etleads to the recruitment cIAP1 to the TRADD-FADD-
al., 2002; Moreno et al., 2002). The later proteins arecaspase 8 complex by TRAF2 and TNF-mediated
functional homolog of mammalian Smac, suggestingactivation of NF-B keeps JNK in check by inhibiting
that the TNF-JNK-Smac pathway is evolutionarily con-sustained activation of JNK. These events prevent
served.TNF-mediated caspase 8 cleavage and apoptosis. In-
A recent study has shown that JNK is not requiredhibition of NF-B allows JNK to induce caspase 8-inde-
for TNF-induced cell death and MEFs deficient forpendent cleavage of Bid at a distinct site to generate a
JNK1 and JNK2 are somewhat more sensitive toBid cleavage product jBid. The jBid protein then translo-
TNF-induced apoptosis, suggesting that JNK plays acates to mitochondria to induce the selective release of
role as survival factor (Lamb et al., 2003). However, pro-Smac, but not cyto c. Smac is then required to relieve
tein synthesis inhibitors CHX and emetine were used inthe inhibition of caspase 8 cleavage and activation. Fur-
these experiments. We have observed that treating cellsthermore, we propose that this inhibition is caused by
with TNF and CHX or RNA synthesis inhibitor Act DTRAF2-cIAP1 within the TRADD-FADD-caspase 8 com-
significantly inhibits TRAF2 and cIAP1 expressions andplex. In support of this hypothesis, we show that an
bypasses JNK-dependent mitochondria requirementactive fragment of Smac can disrupt the interaction be-
(Y.D. and X.W., unpublished data). It is possible that lowtween TRAF2 and cIAP1 upon TNF stimulation. Since
or basal levels of JNK provide protection against cell
cIAP1 does not directly bind to caspase 8 and inhibit
death while sustained activation of JNK, as the one
its activation (Deveraux et al., 1998), the mechanisms
generated by TNF in p65/ cells, overrides the anti-
of TRAF2-cIAP1-mediated inhibition on caspase 8 acti-
apoptotic signals to promote cell death.
vation is likely due to close proximity (TRAF2 brings Although our results indicate that TNF is able to
cIAP1 close to caspase 8 in the TNF signaling com- transduce signal to mitochondria via JNK, the JNK-Bid
plex). This hypothesis is supported by a recently pub- pathway results in only selective release of Smac with-
lished report showing that a single complex containing out affecting cyto c, which is required for caspase 9
TRADD, FADD, caspase 8, TRAF2, and cIAP1 exists in activation. Studies using constitutive active JNK mim-
wild-type cells after TNF stimulation (no cell death), icking sustained JNK activation in TNF signaling to
while cIAP1 in the complex is greatly reduced in cells apoptosis further support this notion. Thus, TNF-medi-
expressing m-iB (cell death) (Micheau and Tschopp, ated JNK activation is insufficient to induce cell death.
2003). This is consistent with our results that no caspase 9
Based on this model, loss of TRAF2 will prevent the cleavage and apoptosis were observed in cells express-
recruitment cIAP1 to the TRADD-FADD-caspase 8 com- ing m-iB and FADD-DN after TNF treatment (data not
plex thereby leaving caspase 8 free of inhibition. This shown). It is also consistent with the finding that caspase
would render TRAF2 null cells hypersensitive to caspase 8 and FADD are required for TNF-mediated apoptosis
8 activation and apoptosis without the necessity for JNK (Varfolomeev et al., 1998; Yeh et al., 1998). Despite our
activation. This is consistent with previously published finding on the role of JNK in TNF-mediated apoptosis,
results using TRAF2 deficient cells where it was ob- it appears that different means of JNK activation and/or
served that TRAF2/ cells were highly sensitive to cell context may lead to different mitochondria effects,
TNF-induced apoptosis although JNK activation was since some previous reports have shown that activation
defective and NF-B activation was mildly affected in of JNK is sufficient to induce apoptosis via mitochondria
these cells (Yeh et al., 1997). Similarly, our hypothesis (Tournier et al., 2000).
predicts that inhibition of cIAP1 expression should also In addition to caspase 8, other proteases such as
sensitize TNF-mediated caspase 8 activation and apo- lysozyme, calpin, and granzyme B, have also been re-
ptosis as is shown to be the case (see Supplemental ported to cleave and activate Bid (Chen et al., 2001;
Data available at http://www.cell.com/cgi/content/full/ Heibein et al., 2000; Stoka et al., 2001; Sutton et al.,
2000), suggesting that multiple pathways exist in cells114/6/61/DC1).
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scanning mutants were generated using QuickChange site directedto activate Bid. JNK is not a protease; therefore, it is
mutagenesis kit (Stratagene) and verified by DNA sequencing. Thelikely that JNK induced a protease to cleave Bid in TNF
resulting fusion proteins with six histidines were translated in a TNTsignaling. This protease activity is readily detected in
T7 transcription/translation kit (Promega) in the presence of 35S-
TNF-treated cytosol extracts in our in vitro Bid cleav- methionine according to the manufacturer’s instructions. The trans-
age assay. Interestingly, the sequence around this lated proteins were added into either reaction buffer (20 mM HEPES-
KOH [pH 7.5], 10 mM KCl, 1.5 mM MgCl2, 1 mM sodium EDTA, 1cleavage site is highly conserved among human, mouse,
mM sodium EGTA, 1 mM dithiothreitol, and 0.1 mM PMSF) or 50and rat. The JNK-mediated Bid cleavage site is much
g cytosol extracts prepared with the reaction buffer and incubatedcloser to its N terminus than other known Bid cleavage,
in a total volume of 25l for 2 hr at 37C. The samples were subjectedwhich could explain why jBid only induces selective
to 12% SDS-PAGE and exposed to X-ray film for 24 hr at 80C.
release of mitochondria factors.
Subcellular Fraction, Immunofluorescence,
Experimental Procedures
Immunoprecipitation, and Western Blot Analysis
All the procedures were performed as described previously (Deng
Antibodies and Other Materials
et al., 2002; Deng and Wu, 2000). Bid antibody (BD-Pharmingen)
We obtained anti-iB, antiphosphorylated iB, anti-JNK, antiphos-
and SuperSignal West Femto-kit (Pierce) were used to detect endog-
phorylated JNK, anti-MKK7, anti-Myc, anti-cIAP1/2, anti-TRAF-1/2,
enous jBid.
and anti-TNFR1 from Santa Cruz Biotechnology. Anti-FADD was
purchased from Signal Transduction Lab. Anti-TRADD and anti-
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for helpful discussions. We also thank Dr. B. Vogelstein at Johnsacquired from R&D systems. Smac N7 and N7np peptides were
Hopkins Medical School for providing HCT116 cells; Dr. P. Chiaopurchased from Calbiochem. Radioactive materials were from
at M.D. Anderson Cancer Center for p65/ cells; and Dr. XiaomingAmersham Biosciences. Cell viability was determined by trypan blue
Yin at University of Pittsburgh for Bid/ MEFs. Dr. R. Agami atexclusion and aspase-8, -3 enzyme activities using enzyme assay
Netherlands Cancer Institute for providing pSUPER; Dr. Rennefahrtkits following by the manufacturer’s instructions (Clontech).
and Dr. Rapp at University of Wuerzburg in Germany for pMKK7-
JNK-wt and -kd plasmids; Dr. Hunter at Children’s Hospital of East-Construction of Plasmids
ern in Ontario, Canada, for Ub-Smac and Ub-AVPI-Smac cDNA;The m-iB (deleted N-terminal 31 amino acids, S32A and T36A
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